Molecular Insight Pharmaceuticals, Inc.
http://www.molecularinsight.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Molecular Insight Pharmaceuticals, Inc.
Gottlieb's Confirmation: Will Industry Ties Remain A Problem After The Hearing?
The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be a lasting problem.
Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?
The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be lasting problem.
People Briefs
CardioDx appoints president and CEO; FDA device review veteran joins Hogan Lovells; TransEnterix names new senior surgical office; and more personnel updates from around the industry.
US Capitol Capsule: Rare disease research hopeful, but therapy success remains low
It used to be that the FDA's regulatory focus on therapies to treat rare diseases involved only a small segment of the agency's activities.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice